PUBLIC CONTRACT · 2021
Medicamentos Baricitinib, Brodalumab, Axitinib, Golimumab, Ciclofosfamida e Capecitabina
- Contract value
- €69,753.01
- Signed on
- 9 December 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10846292PUBLISHED SUBJECT
41/5160/2021 - Medicamentos Baricitinib, Brodalumab, Axitinib, Golimumab, Ciclofosfamida e Capecitabina
WHO CONTRACTED
Parties involved
- Awardee
- R2MC - Rangel, Produtos Farmacêuticos, S.A.; Baxter Médico Farmacêutica, Lda.; LILLY PORTUGAL - PRODUTOS FARMACEUTICOS; Accord Healthcare, Unipessoal Lda; Merck Sharp & Dohme, Lda; Laboratório Pfizer, Lda.
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- R2MC - Rangel, Produtos Farmacêuticos, S.A. · Tax ID 510599818
- Awardee
- Baxter Médico Farmacêutica, Lda. · Tax ID 503347345
- Awardee
- LILLY PORTUGAL - PRODUTOS FARMACEUTICOS · Tax ID 500165602
- Awardee
- Accord Healthcare, Unipessoal Lda · Tax ID 508622263
- Awardee
- Merck Sharp & Dohme, Lda · Tax ID 500191360
- Awardee
- Laboratório Pfizer, Lda. · Tax ID 500162166
- Bidder
- LEO FARMACEUTICOS · Tax ID 503932680
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €69,753.01
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 31 July 2024
- Award date
- 9 December 2021
- Signing date
- 9 December 2021
- Performance period
- 31 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5665343
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.